Stay Alert for Switches to Rytary From Other Carbidopa/Levodopa Products

You'll see Rytary (rye-TAR-ee), which is a new extended-release formulation of carbidopa/levodopa for Parkinson's disease.

Think of Rytary as having the benefits of both carbidopa/levodopa immediate-release (Sinemet) and sustained-release (Sinemet CR).

It starts to work within about an hour, similar to carbidopa/levodopa IR...but lasts longer, similar to carbidopa/levodopa CR.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote